Polycystic ovarian syndrome (PCOS) related symptoms/sequelae, and breast cancer risk in a population based case control study
PurposeDespite the overlap between the clinical symptoms/sequelae of polycystic ovarian syndrome (PCOS) and many known reproductive risk factors for breast cancer, the relationship between PCOS and breast cancer remains unclear, possibly because of the complex heterogeneity and challenges in diagnosing PCOS over time. We hypothesized that PCOS, specific PCOS related symptoms/sequelae, or clusters of PCOS related symptoms/sequelae may be differentially associated with pre versus postmenopausal breast cancer risk.Materials and methodsCases were 1,508 women newly diagnosed with a first primary in situ or invasive breast, and the 1,556 population based controls were frequency matched by age.ResultsHistory of physician diagnosed PCOS was reported by 2.2 (n 67) among whom oral contraceptive (OC) use, irregular menstruation, and infertility due to ovulatory dysfunction were common. Using unconditional logistic regression, adjusted odds ratios (95 CI) for PCOS were increased for premenopausal [2.74 (1.13, 6.63) but not postmenopausal breast cancer [0.87 (0.44, 1.71) We used cluster analysis to investigate whether risk among all women varied by PCOS related symptoms/sequelae, such as reproductive irregularities, OC use, and components of insulin resistance. In the cluster analysis, odds ratios were elevated among premenopausal women who had a history of OC use and no ovulatory dysfunction [1.39 (1.03, 1.88) compared to those with fewer number of PCOS related symptoms/sequelae.ConclusionPCOS and associated PCOS related symptoms/sequelae including OC use may play a role in the development of premenopausal breast cancer. Our findings require confirmation in studies with a larger number of premenopausal women with systematically applied diagnostic criteria for PCOS.
Cancer Causes Control